Drug
QLS31905
QLS31905 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(20%)
Phase Distribution
Ph phase_3
2
40%
Ph phase_1
2
40%
Ph phase_2
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Other(2)
Detailed Status
unknown2
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Trials by Status
unknown240%
not_yet_recruiting240%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_3
QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ
NCT07716449
recruitingphase_3
A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer
NCT07079228
not_yet_recruitingphase_2
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
NCT06446388
unknownphase_1
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
NCT06041035
unknownphase_1
A Study of QLS31905 in Patients With Advanced Solid Tumors
NCT05278832
Clinical Trials (5)
Showing 5 of 5 trials
NCT07716449Phase 3
QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ
NCT07079228Phase 3
A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer
NCT06446388Phase 2
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
NCT06041035Phase 1
A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
NCT05278832Phase 1
A Study of QLS31905 in Patients With Advanced Solid Tumors
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5